DK1064014T3 - Lægemiddel til forebyggelse eller behandling af papillomvirusspecifik tumor - Google Patents

Lægemiddel til forebyggelse eller behandling af papillomvirusspecifik tumor

Info

Publication number
DK1064014T3
DK1064014T3 DK99916884T DK99916884T DK1064014T3 DK 1064014 T3 DK1064014 T3 DK 1064014T3 DK 99916884 T DK99916884 T DK 99916884T DK 99916884 T DK99916884 T DK 99916884T DK 1064014 T3 DK1064014 T3 DK 1064014T3
Authority
DK
Denmark
Prior art keywords
drug
prevention
treatment
papilloma virus
specific tumor
Prior art date
Application number
DK99916884T
Other languages
English (en)
Inventor
Alexander Burger
Michael Hallek
Original Assignee
Medigene Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medigene Ag filed Critical Medigene Ag
Application granted granted Critical
Publication of DK1064014T3 publication Critical patent/DK1064014T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5258—Virus-like particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/58—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation
    • A61K2039/585—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation wherein the target is cancer
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Communicable Diseases (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Mycology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK99916884T 1998-03-24 1999-03-24 Lægemiddel til forebyggelse eller behandling af papillomvirusspecifik tumor DK1064014T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19812941A DE19812941A1 (de) 1998-03-24 1998-03-24 Arzneimittel zur Vermeidung oder Behandlung von Papillomavirusspezifischem Tumor
PCT/EP1999/001996 WO1999048518A2 (de) 1998-03-24 1999-03-24 Arzneimittel zur vermeidung oder behandlung von papillomavirus-specifischem tumor

Publications (1)

Publication Number Publication Date
DK1064014T3 true DK1064014T3 (da) 2005-05-30

Family

ID=7862148

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99916884T DK1064014T3 (da) 1998-03-24 1999-03-24 Lægemiddel til forebyggelse eller behandling af papillomvirusspecifik tumor

Country Status (12)

Country Link
EP (1) EP1064014B1 (da)
JP (1) JP2002509863A (da)
AR (1) AR014768A1 (da)
AT (1) ATE288279T1 (da)
AU (1) AU755242B2 (da)
CA (1) CA2323573A1 (da)
DE (2) DE19812941A1 (da)
DK (1) DK1064014T3 (da)
ES (1) ES2237913T3 (da)
MX (1) MXPA00009282A (da)
PT (1) PT1064014E (da)
WO (1) WO1999048518A2 (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE514982C2 (sv) * 1999-09-30 2001-05-28 Active Biotech Ab Bärare innehållande ett huvudkapsidprotein L1 från humant papillomavirus samt dess användning
DE10059630A1 (de) * 2000-12-01 2002-06-06 Medigene Ag Arzneimittel zur Vermeidung oder Behandlung von durch humanen Papillomavirus-Typ 18-hervorgerufenem Tumor
JP4614765B2 (ja) † 2002-05-17 2011-01-19 ユニバーシティ・オブ・ケープ・タウン Ｌ２ペプチドを含むキメラ・ヒト・パピローマウイルス１６ｌ１タンパク質、それから調製したウイルス様粒子および該粒子の調製方法
JP5186678B2 (ja) * 2005-10-13 2013-04-17 財団法人ヒューマンサイエンス振興財団 経皮抗原投与のための抗原キット

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4447664C2 (de) * 1994-10-07 1999-04-15 Lutz Prof Dr Gissmann Fusionsproteine, Verfahren zu deren Herstellung sowie deren Anwendung

Also Published As

Publication number Publication date
WO1999048518A2 (de) 1999-09-30
PT1064014E (pt) 2005-06-30
ES2237913T3 (es) 2005-08-01
AU3521499A (en) 1999-10-18
AR014768A1 (es) 2001-03-28
DE59911556D1 (de) 2005-03-10
EP1064014B1 (de) 2005-02-02
AU755242B2 (en) 2002-12-05
MXPA00009282A (es) 2002-12-13
EP1064014A2 (de) 2001-01-03
WO1999048518A3 (de) 1999-12-02
CA2323573A1 (en) 1999-09-30
JP2002509863A (ja) 2002-04-02
DE19812941A1 (de) 1999-10-07
ATE288279T1 (de) 2005-02-15

Similar Documents

Publication Publication Date Title
DK1093370T3 (da) Farmaceutisk præparat til behandling af diabetes
DK1427437T3 (da) Oxyntomodulin til forebyggelse eller behandling af overvægt
DK1147083T3 (da) Arylpiperazinyl-cyclohexylindolderivater til behandling af depression
ATE231683T1 (de) Matte zur abgabe von flüchtigen stoffen
DK1123284T3 (da) Fremgangsmåde til fremstilling af citalopram
DE60019556D1 (de) 2-amino-benzoxazinonderivate zur behandlung von fettleibigkeit
DK1173431T3 (da) Fremgangsmåde til fremstilling af citalopram
DK1021194T3 (da) Ny forbedret formulering til behandling af osteoporose
DK1105382T3 (da) Fremgangsmåde til fremstilling af citalopram
DK1032566T5 (da) Fremgangsmåde til fremstilling af citalopram
DK1159274T3 (da) Fremgangsmåde til fremstilling af citalopram
DK1063990T3 (da) Anvendelse af Biochanin-beriget ekstrakt til behandling af östrogen-associerede lidelser
DE60019555D1 (de) 2-oxy-benzoxazinonderivate zur behandlung von fettleibigkeit
DE60019158D1 (de) Neue oxabispidin-verbindungen zur behandlung von herzarrhythmien
NO20022087L (no) Fremgangsmåte for behandling av diabetes
DE60030554T8 (de) Verwendungen von et743 zur behandlung von krebs
DK199800837A (da) Anlæg til behandling af emner
DK1041985T3 (da) Kombination af benzocycloheptapyridinforbindelser og antineoplastiske lægemidler til behandling af profilerative sygdomme
ATE347372T1 (de) Vakzine zur behandlung von mycosen
DE50011325D1 (de) Vorrichtung zur Erkennung der Kreislaufwirkungen von Extrasystolen
ATE253578T1 (de) Oxazinochinolone zur behandlung von viralen infektionen
DK1064014T3 (da) Lægemiddel til forebyggelse eller behandling af papillomvirusspecifik tumor
DK1228056T3 (da) Fremgangsmåde til fremstilling af citalopram
NO983784L (no) Fremgangsmåter for fremstilling av bifenyl-isoksasolsulfonamider
DK1012152T3 (da) Fremgangsmåde til fremstilling af oxazaphosphorin-2-aminer